<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is the most common human B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in the United States and Western Europe </plain></SENT>
<SENT sid="1" pm="."><plain>Most of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> contain t(14;18) chromosome translocations involving the human bcl-2 gene </plain></SENT>
<SENT sid="2" pm="."><plain>Translocation of bcl-2 sequences from chromosome 18 into the transcriptionally active immunoglobulin locus at chromosome band 14q32 in B cells deregulates bcl-2 gene expression, resulting in the accumulation of high levels of bcl-2 messenger </plain></SENT>
<SENT sid="3" pm="."><plain>Human bcl-2 transcripts generate two proteins, p26 bcl-2-alpha and p22 bcl-2-beta, by virtue of alternative splice-site selection </plain></SENT>
<SENT sid="4" pm="."><plain>Both proteins have in common their first 196 NH2-terminal amino acids but share little similarity with other sequences in a data bank </plain></SENT>
<SENT sid="5" pm="."><plain>Although the biological and biochemical functions of bcl-2 are unknown, recent subcellular localization studies indicate that p26 bcl-2-alpha associates with cellular membranes, consistent with a stretch of hydrophobic amino acids in its carboxy terminus </plain></SENT>
<SENT sid="6" pm="."><plain>The bcl-2 gene may represent a novel oncogene having no known retroviral counterpart </plain></SENT>
<SENT sid="7" pm="."><plain>Here we demonstrate the oncogenic potential of bcl-2 through a gene transfer approach </plain></SENT>
</text></document>